Expression of monoclonal-antibody-defined antigens in fractions isolated from human breast carcinomas and patients' serum (original) (raw)
References
Abecassis J, Petit JC, Eber M, Klein T, Rodier D, Jauser JC, Methlin G (1985) Complexes immuns circulants dans le cancer du sein. Bull Cancer (Paris) 72: 42 Google Scholar
Beard D, Haskell C (1986) Carcinoembryonic antigen in breast cancer. Am J Med 80: 241 PubMed Google Scholar
Bocker W, Schweikart G, Pollow K (1985) Immunohistochemical demonstration of carcinoembryonic (CEA) in 120 mammary carcinomas and its correlation with tumor type, grading, staging, plasma-CEA and biochemical receptor status. Pathol Res Pract 180: 490 PubMed Google Scholar
Brown A, Feizi T, Gooi HC, Embleton M, Picard J, Baldwin RW (1983) A monoclonal antibody against human colonic adenoma recognizes difucosylated type-2 blood group chains. Biosci Rep 3: 163 PubMed Google Scholar
Creighton WD, Lambert PH, Miescher PA (1973) Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol. J Immunol 11: 1219 Google Scholar
Croce MV, Pasqualini RS, Segal-Eiras A (1987) Circulating immune complexes in breast cancer patients. Medicina 47: 371 PubMed Google Scholar
Croce MV, Segal-Eiras A (1992) Circulating immune complexes (CIC) and carcinoembryonic antigen in patients with colorectal cancer. J Exp Clin Cancer Res 11: 223 Google Scholar
Dixon AR, Price MR, Hand CW, Sibley PEC, Selby C, Blamey RW (1993) Epithelial mucin core antigen (EMCA) in assessing therapeutic response in advanced breast cancer — a comparison with CA15.3. Br J Cancer 68: 947 PubMed Google Scholar
Ellis IO, Hinton CP, MacNay J, Elston CW, Robins A, Owainati A, Blamey RW, Baldwin RW, Ferry B (1985) Immunocytochemical staining of breast carcinoma with the monoclonal antibody NCRC 11: a new prognostic indicator. Br Med J 290: 881 Google Scholar
Gamble AR, Bell JA, Ronan SE, Pearson D, Ellis IO (1993) Use of tumour marker immunoreactivity to identify primary site of metastatic cancer. Br Med J 306: 295 Google Scholar
Gander JE (1984) Gel protein stains: glycoproteins. Methods Enzymol 104: 447 PubMed Google Scholar
Gilead Z, Troy F, Sulitzeanu D (1981) Isolation and electrophoretic analysis of immune complexes from patients with breast cancer. Eur J Cancer Clin Oncol 17: 1165 PubMed Google Scholar
Gourevitch M, Mensdorff-Pouilly SV, Litvinov SV, Verstraeten A, Van Kamp GJ, Kenemans P, Hilgers J (1993) Circulating immune complexes involving polymorphic epithelial mucin (PEM) might impair CA15.3 assay results (abstract). In: Klapdor R (ed) 7th Hamburg Symposium on Tumour Markers. p. 57
Gupta RK, Leitch A, Morton DL (1983) Detection of tumour associated antigen in eluates from protein A columns used for ex vivo immunoadsorption of plasma from melanoma patients by radioimmunoassay. Clin Exp Immunol 53: 589 PubMed Google Scholar
Herberman R, Bordes M, Lambert P, Luthra H, Robins RA, Sizaret PH, Theofilopoulos A (1981) Report on international comparative evaluation of possible value of assays for IC for diagnosis of human breast cancer. Int J Cancer 27: 569 PubMed Google Scholar
Höffken K, Meredith ID, Robins RA, Baldwin RW, Davies CJ, Blamey RW (1978) Immune complexes and prognosis of human breast cancer. Lancet 1: 672 Google Scholar
Idikio HA, Manickavel V (1991) Lewis blood group antigens (a and b) in human breast tissues: loss of lewis-b in breast cancer cells and correlation with tumour grade. Cancer 68: 1303 PubMed Google Scholar
Ioannides CG, Fisk B, Jerome KR, Wharton JT, Finn OJ (1993) Cytotoxic T-cells from ovarian malignant tumors can recognise polymorphic epithelial mucin core peptides. J Immunol 151: 3693 PubMed Google Scholar
Jerome K, Barnd D, Bendt K, Boyer C, Taylor-Papadimitriou J, McKenzie I, Bast R, Finn OJ (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51: 2908 PubMed Google Scholar
Kiang D, Greenberg L, Kennedy B (1990) Tumour marker kinetics in the monitoring of breast cancer. Cancer 65: 193 PubMed Google Scholar
Kotera Y, Fontenot D, Pecher G, Metzgar RS, Finn OJ (1994) Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast pancreatic and colon cancer patients. Cancer Res 54: 2856 PubMed Google Scholar
Laemmli UK (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond) 227: 680 Google Scholar
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265 PubMed Google Scholar
Mensdorff-Pouilly SV, Gourevitch M, Verstraeten A, Van Kamp GJ, Kenemans P, Hilgers J (1993) Circulating immune complexes containing polymorphic epithelial mucin (PEM) in benign breast tumor and breast and ovarian cancer patients (abstract). In: Klapdor (ed) 7th Hamburg Symposium on Tumour Markers, p. 56
Mughal AW, Hortobagyi GN, Iritsche H, Buzdar AU, Yap HY, Blumenschein GR (1983) Serial plasma carcinoembryonic antigen measurements during treatment of metastatic breast cancer. JAMA 249: 1881 PubMed Google Scholar
Narita T, Funahashi H, Satoh Y, Watanabe T, Sakamoto J, Takagi H (1993) Association of expression of blood group-related carbohydrate antigens with prognosis in breast cancer. Cancer 71: 3044 PubMed Google Scholar
Neri B, Comparini T, Ciatto S, Cataliotti L, Distante V, Bartalucci S (1985) Circulating immune complexes (CIC) as tumor markers in the follow up of breast cancer. Cancer Detect Prev 8: 53 PubMed Google Scholar
Papsidero L, Namoto T, Snyderman M, Chu T (1979) Immune complexes in breast cancer patients as detected by C1q binding. Cancer 44: 1636 PubMed Google Scholar
Price MR (1988) Epitopes of carcinoembryonic antigen (CEA) defined by monoclonal antibodies. Br J Cancer 57: 165 PubMed Google Scholar
Price MR, Campbell DG, Robins RA, Baldwin RW (1983) Characteristics of a cell surface antigen defined by anti-human osteogenic sarcoma monoclonal antibody. Eur J Cancer Clin Oncol 19: 81 PubMed Google Scholar
Price MR, Edwards S, Owainati A, Bullock JE, Ferry B, Robins RA, Baldwin RW (1985) Multiple epitopes on a human breast carcinoma associated antigen. Int J Cancer 36: 567 PubMed Google Scholar
Price MR, Hudecz F, O'Sullivan C, Baldwin RW, Edwards P, Tendler S (1990) Immunological and structural features of the protein core of human polymorphic epithelial mucin. Mol Immunol 27: 795 PubMed Google Scholar
Repetto L, Onetto M, Gardin G, Costanzi B, Giudici S, Vitiello E, Merlini L, Naso C, Zannini C, Paganuzzi M (1993) Serum CEA, CA 15-3 and MCA in breast cancer patients: a clinical evaluation. Cancer Detect Prev 17: 411 PubMed Google Scholar
Robertson JF, Ellis IO, Bell J, Todd JH, Robins RA, Elston W, Blamey RW (1989) Carcinoembryonic antigen immunocytochemistry in primary breast cancer. Cancer 64: 1638 PubMed Google Scholar
Robertson JFR, Pearson D, Price MR, Selby C, Pearson J, Blamey RW, Howell A (1991) Prospective assessment of the role of five serum markers in breast cancer. Cancer Immunol Immunother 33: 403 PubMed Google Scholar
Rughetti A, Turchi V, Ghetti CA, Scambia G, Panici PB, Roncucci G, Mancuso SM, Frati L, Nuti M (1993) Human B-cell immune response to the polymorphic epithelial mucin. Cancer Res 53: 2457 PubMed Google Scholar
Tondini C, Hayes DE, Gelman R, Henderson IC, Kufe DW (1988) Comparison of CA 15.3 and carcinoembryonic antigen in monitoring the clinical course of patients with metastatic breast cancer. Cancer Res 48: 4107 PubMed Google Scholar
Towbin H, Staehelin T, Gordon J (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedures and some applications. Proc Natl Acad Sci USA 76: 4350–4354 PubMed Google Scholar
Von Kleist S, Bombardieri E, Buraggi G, Gion M, Hertel A, Hor G, Noujaim A, Schwatrz M, Senekowitsch R, Wittekind C (1993) Immunodiagnosis of tumours. Eur J Cancer 29 A: 1622 Google Scholar